Cascadian Therapeutics, Inc. Accrued Liabilities, Current
Cascadian Therapeutics, Inc. had Accrued Liabilities, Current of $6.08 million as of 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2018-03-08
- 2017-12-31: Accrued Liabilities, Current $6.08M.
- 2017-09-30: Accrued Liabilities, Current $5.45M.
- 2017-06-30: Accrued Liabilities, Current $5.10M.
- 2017-03-31: Accrued Liabilities, Current $2.96M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2017-12-31 | $6.08M 10-K · filed 2018-03-08 | |
| 2017-09-30 | $5.45M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $5.10M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $2.96M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $3.32M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $2.66M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $2.17M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $3.07M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $2.69M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $1.49M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.53M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $2.23M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.82M 10-K · filed 2016-03-14 | $2.13M 10-K · filed 2015-03-10 |
| 2014-09-30 | $3.03M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $2.06M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $1.70M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $2.62M 10-K · filed 2015-03-10 | |
| 2013-09-30 | $1.92M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $2.10M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $1.69M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $852.00K 10-K · filed 2014-03-13 | |
| 2012-09-30 | $1.01M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $2.22M 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $980.00K 10-Q/A · filed 2012-08-13 | |
| 2011-12-31 | $1.48M 10-K · filed 2013-03-14 | $1.29M 10-K · filed 2012-03-09 |
| 2011-09-30 | $943.00K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $1.10M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $533.00K 10-K/A · filed 2012-08-13 |